Sandhya Ganesan Yale School of Medicine
2 protocols

Shyam Srivats University of California, San Francisco
3 protocols

Anand Ravindran
  • Research scientist, GlaxoSmithKline
Research focus
  • Cancer biology
  • Immuno-Oncology, Target identification and discovery, Cell biology


PhD, Penn State, 2013

Lab information

Discovery Oncology

1 Protocol reviewed
In vitro STING Activation with the cGAMP-STINGΔTM Signaling Complex
Authors:  Yanpu He, Celestine Hong, Darrell J. Irvine, Jiahe Li and Paula T. Hammond, date: 02/05/2021, view: 2351, Q&A: 0
Activating the STING (stimulator of interferon genes) signaling pathway via administration of STING agonist cyclic GMP-AMP (cGAMP) has shown great promise in cancer immunotherapy. While state-of-the-art approaches have predominantly focused on the ...
More >
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.